Frank Ferrante

Mr. Ferrante joined Cambrex in March 2022 and currently serves as Chief Mergers & Acquisitions Officer. Mr. Ferrante previously held the position of Vice President, M&A and Business Development at Quest Diagnostics where he led company-wide M&A and business development efforts, including sourcing and execution of acquisitions and divestitures as well as enterprise level partnerships. Prior to that, Mr. Ferrante held roles of increasing responsibility in Corporate Development at Thermo Fisher Scientific and in management consulting at Bain & Company.